- Home
- CDNL vs INMD Comparison
CDNL vs INMD Comparison
Compare CDNL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$14.36
Company Overview
Basic Information| Metric | CDNL | INMD |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 879.2M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CDNL | INMD |
|---|---|---|
| Price | $27.50 | $14.36 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.9M | 581.0K |
| Earning Date | 01-01-0001 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ 1915.40 | 2.21 |
| Revenue | ★ $395,162,963.00 | $364,494,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ $0.02 | $6.56 |
| Revenue Growth | ★ 59.39 | N/A |
| 52 Week Low | $22.73 | $13.14 |
| 52 Week High | $29.75 | $19.78 |
Technical Indicators
Market Signals| Indicator | CDNL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.58 |
| Support Level | N/A | $14.24 |
| Resistance Level | N/A | $14.58 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 0.00 | 62.64 |
Price Performance
Historical Comparison CDNL
INMD
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.